Latest update January 31st, 2025 4:34 AM
Latest News
- Renegotiation – the games politicians play
- Increased oil production in Guyana helped drive higher profit for Hess Corporation
- Patterson, Edghill clash over viability of Amaila Falls Hydro Project
- Thirty killed in crowd crush at India’s Kumbh Mela festival
- Taxi driver, watchman nabbed with 𝟐𝟏,𝟑𝟔𝟒 𝐠𝐫𝐚𝐦𝐬 𝐨𝐟 ganja
Guyana looking to India to help meet its ‘safe medicines’ demands
“Only safe and effective medicines will be made available to Guyanese citizens.”
This was the assertion of public health officials as they engaged potential suppliers of pharmaceuticals to the local market.
The potential suppliers are from India and the move to embrace this level of collaboration is a direct result of Guyana and India’s mutual cooperation in health to ensure only pharmaceuticals, drugs and medicines deemed safe by Guyanese authorities will be sold here.
This was the focus of a discussion between key representatives of the two countries recently.
According to information released by the Public Health Ministry yesterday, on Tuesday Director of Pharmacy, Mr. Oneil Atkins, and Director of the Government Analyst Food and Drug Department [GA-FDD], Mr. Marlan Cole, took the opportunity to outline the country’s strict public health policies during a recent meeting.
The two-day meeting was held with representatives of the Indian Chambers of Commerce and the Pharmaceutical Export Promotion Board on the sidelines of the just-concluded Fourth International Conference on Pharmaceuticals and Medical Devices held in Bengaluru, India. According to Atkins, the two countries ha
Mr. Oneil Atkins and Mr. Marlan Cole [second and third from left] in the presence of Indian officials at the 4th International Conference on Pharmaceuticals and Medical Devices held in Bengaluru, India.
The Fourth International Conference on Pharmaceuticals and Medical Devices was held under the theme ‘Enabling Quality Affordable Healthcare’.
During the annual conference, Cole challenged the representatives to “do all in their power” to encourage manufacturers in India desiring a stake in the global drug market to ensure their products can withstand international scrutiny of reputable medicines reference authorities.
During the interview, Cole also outlined Guyana’s requirements for registration of medicines in the country. Even as Atkins alluded to the fact that the Indian manufacturers seek to assure quality export products will be made available, he strongly advocated that other manufacturers follow their example.
Participants from some 30 countries including Russia, Kenya, the United Kingdom [UK], Malaysia, Indonesia, Saudi Arabia and Uzbekistan, along with drug regulators from 15 Indian states attended the conference which was organised by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers and the Government of India in collaboration with the Federation of Indian Chambers of Commerce and Industry [FICCI].
Some of the issues discussed included development of separate medical devices and over-the-counter [OTC] drug regulations; early decision on implementation of trade margin rationalization and addressing the issue of Active Pharmaceutical Ingredients [APIs] price escalation imported from China; incentivising innovations in the pharmaceutical and medical devices sector, and greater transparency in the functioning of National Pharmaceutical Pricing Authority [NPPA].
Similar Articles
THE BLUNT OF THE DAY
Sports
Features/Columnists
The third parties will not survive this year’s elections
Peeping Tom… Kaieteur News- The fate of third parties in this year’s general and regional elections is as predictable... more
OAS Secretary General Election and renewed OAS Consensus
Antiguan Barbudan Ambassador to the United States, Sir Ronald Sanders By Sir Ronald Sanders Kaieteur News- The upcoming election... more
Weekend Cartoon
